In one of the largest studies conducted to date, a new heart pump, or left ventricular assist device (LVAD), demonstrated a four-fold increase in the survival of advanced heart failure patients without a stroke or device failure.

Duke Heart Center at Duke University Hospital (DUH) has received the American College of Cardiology Foundation’s NCDR ACTION Registry–GWTG Gold Performance Achievement Award for 2009 -- one of only 121 hospitals nationwide to do so.

At the moment a newborn switches from amniotic fluid to breathing air, another profound shift occurs: nerve cells in the brain convert from hyperexcitability to a calm frame against which outside signals can be detected.

Chemical fingerprints produced by the body’s normal metabolic processes predict who will suffer cardiovascular events and who will benefit from weight loss by reduction of insulin resistance, according two new studies by researchers at Duke University Medical Center.

Acute heart attack patients receive an average dose of radiation that is 30 percent of the recommended annual limit -- equal to 725 chest X-rays -- during an average hospital admission, according to researchers at Duke University Medical Center.

Two large studies confirmed that an investigational, reversible anti-clotting medication failed to show greater effectiveness than clopidogrel or a placebo for patients undergoing a procedure to open blocked coronary arteries, according to researchers at the Duke Clinical Research Institute. However, some data in the study suggest the potential for a different, more targeted use for cangrelor.

To address the need for more information to help improve the care of patients with atrial fibrillation, the Duke Clinical Research Institute (DCRI) is launching the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). ORBIT-AF is a prospective, longitudinal, observational study, scheduled to begin in December, which will evaluate treatment patterns and the subsequent outcomes of 10,000 patients in the United States.

New Delhi, India -- Medanta – The Medicity and Duke Medicine today signed a joint venture agreement with the vision to launch the Medanta Duke Research Institute (MDRI), a world class early phase clinical research facility at Medanta.

Duke University and Jubilant Organosys partner to advance both organizations’ mutual commitment to reducing global health disparities.

A very close and detailed study of how the most robust antibodies work to block the HIV virus as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine.

State and local dignitaries will join leaders of Duke Medicine this Friday, Nov. 6, 2009), in breaking ground for the new Duke Medicine Cancer Center.

A new model for conducting prevention research in Alzheimer’s disease is being launched by Duke University Medical Center assisted by the Eastern North Carolina Chapter of the Alzheimer's Association.

R. Sanders “Sandy” Williams, MD, senior vice chancellor for academic affairs at Duke University, has been named the new president of The J. David Gladstone Institutes, an independent non-profit biomedical research institute affiliated with the University of California, San Francisco. Williams leaves Duke after having served for six years as dean of the Duke University School of Medicine and, most recently, two years as Senior Vice Chancellor for Academic Affairs.

Researchers at Duke University Medical Center have uncovered a new genetic signature that correlates strongly with autism and which doesn

Tests performed by the Centers for Disease Control and Prevention (CDC) at the request of infectious disease experts at Duke University Medical Center have confirmed this week that isolates from four patients with H1N1 influenza at Duke University Hospital over the past six weeks were found to be resistant to oseltamivir (Tamiflu). Two oseltamivir-resistant H1N1 isolates were reported in western North Carolina earlier this summer.

In one of the largest studies conducted to date, a new heart pump, or left ventricular assist device (LVAD), demonstrated a four-fold increase in the survival of advanced heart failure patients without a stroke or device failure.

Duke Heart Center at Duke University Hospital (DUH) has received the American College of Cardiology Foundation’s NCDR ACTION Registry–GWTG Gold Performance Achievement Award for 2009 -- one of only 121 hospitals nationwide to do so.

At the moment a newborn switches from amniotic fluid to breathing air, another profound shift occurs: nerve cells in the brain convert from hyperexcitability to a calm frame against which outside signals can be detected.

Chemical fingerprints produced by the body’s normal metabolic processes predict who will suffer cardiovascular events and who will benefit from weight loss by reduction of insulin resistance, according two new studies by researchers at Duke University Medical Center.